ArticleJournal of animal science2025
Effects of spray-dried plasma on nutrient digestibility, fecal metabolites, microbiota, and immune and inflammatory biomarkers in adult dogs.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spray-dried plasma (SDP) is a high-quality protein source with functional properties that support gut health, immune function, and digestibility. Although its benefits have been demonstrated in various animal species (e.g., swine, poultry, rodents, and fish), further research is needed to understand its specific effects in extruded diets and canine health. This study evaluated the effects of incorporating SDP from swine, in partial replacement of chicken meal, into extruded diets on nutrient digestibility, fecal metabolites, microbiota composition, serum chemistry, and inflammatory and immune biomarkers in adult dogs. Extrusion processing parameters were also evaluated in diets containing increasing levels of SDP. Four dietary treatments were formulated: a Control diet without SDP, a diet with 4% SDP applied as a coating (4% coating diet), and diets with 4% or 8% SDP included within the kibble matrix prior to extrusion. Twelve adult Beagles (n = 12) were assigned to the four dietary treatments in a replicated 4 × 4 Latin Square design, with each diet fed for 21 d following a 7-d adaptation period. All diets were well accepted by the dogs. Feeding 8% SDP maintained overall nutrient digestibility but reduced total dietary fiber digestibility (P < 0.05). Fecal concentrations of short-chain fatty acids, particularly propionate, were higher in dogs fed the 8% SDP diet (193.8 µmol/g) compared with the Control diet (126.8 µmol/g; P < 0.05). Additionally, a linear reduction in protein fermentation byproducts, mainly indole metabolites, was observed, suggesting a beneficial shift in microbial metabolism (P < 0.05). Inclusion of SDP also modulated fecal microbiota composition, with changes across several genera and increases in beneficial genera such as Lactobacillus, Streptococcus, and Catenibacterium, while also affecting beta-diversity (P < 0.05). Serum chemistry analysis showed lower blood urea nitrogen in dogs fed the 4% Coating SDP (17.8 mg/dL), 4% SDP (18.0 mg/dL), and 8% SDP (16.3 mg/dL) diets compared with the Control diet (19.8 mg/dL; P < 0.05), suggesting improved protein metabolism. Fecal IgA concentrations were higher in dogs fed 8% SDP than the Control diet, indicating potential immunomodulatory effects that may contribute to improved intestinal homeostasis (P < 0.05). These findings support the potential of SDP as a functional ingredient in canine diets, contributing to gut health, metabolic regulation, and immune function in extruded pet food.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.